AHA blog: PhRMA report misleads on drug costs
Instead of attacking hospitals and health systems caring for patients during the COVID-19 pandemic, PhRMA should instead focus on lowering the costs of drugs for Americans, writes AHA Executive Vice President Tom Nickels.
Related News Articles
Headline
Learn how Loyola University Health System’s pop-up COVID-19 testing laboratory broadened collaboration between clinicians and hospital leadership, improved…
Headline
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday urged the U.S.…
Headline
A recent op-ed in the online publication STAT contains “blatant factual inaccuracies” and omits critical information about hospital and health systems’…
Headline
The Health Resources and Services Administration yesterday released another $450 million in American Rescue Plan Act payments to rural health care providers to…
Headline
AHA today launched a new suite of resources for rural health care leaders, including an on-demand webinar and playbook. The webinar features rural hospital…
Headline
Join the AHA April 28 at 2 p.m. ET for a discussion with rural hospital leaders and board members on caring for patients during the COVID-19 pandemic, building…